Showing results (1201-1210 of 3,339) with videos related to
Sort By:
Pageof 334
Metabolic Brain Disease|May 29, 2012
CYP2D6 genotyping and use of antidepressants in breast cancer patients: test development for clinical applicationNicole van der Merwe, Christianne S H Bouwens, Rika Pienaar, et al.Metabolic Brain Disease|May 16, 2012
Ethylmalonic encephalopathy associated with crescentic glomerulonephritisImad Dweikat, Enas Naser, Nadera Damsah, et al.Metabolic Brain Disease|May 23, 2012
IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depressionMichael Maes, Ivana Mihaylova, Marta Kubera, et al.Metabolic Brain Disease|November 27, 2012
Excessive daytime sleepiness and hepatic encephalopathy: it is worth askingMichele De Rui, Sami Schiff, Daniele Aprile, et al.Metabolic Brain Disease|December 3, 2013
Memory deficits associated with sublethal cyanide poisoning relative to cyanate toxicity in rodentsS Kimani, K Sinei, F Bukachi, et al.Metabolic Brain Disease|November 13, 2013
Glia activation and its role in oxidative stressOlalekan Michael Ogundele, Adams Olalekan Omoaghe, Duyilemi Chris Ajonijebu, et al.Metabolic Brain Disease|October 30, 2013
Bridging the Gap: establishing the necessary infrastructure and knowledge for teaching and research in neuroscience in AfricaSadiq Yusuf, Tom Baden, Lucia L Prieto-GodinoMetabolic Brain Disease|September 26, 2013
Predominant gray matter volume loss in patients with end-stage renal disease: a voxel-based morphometry studyLong Jiang Zhang, Jiqiu Wen, Ling Ni, et al.Metabolic Brain Disease|June 1, 1994
Genetics of alcoholism: role of the endogenous opioid systemC Gianoulakis, J P de WaeleMetabolic Brain Disease|September 1, 1993
Spatial and temporal changes in tissue pH and ATP distribution in a new model of reversible focal forebrain ischemia in the ratD Bereczki, L CsibaPageof 334